Euzebio G. Barbosa

Natal, RN 59012570, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Insights into a new class of antileishmanial compounds: an in vitro and in silico study of 1,2,4-oxadiazol-5(4H)-one derivatives.

Insights into a new class of antileishmanial compounds: an in vitro and in silico study of 1,2,4-oxadiazol-5(4H)-one derivatives.

Journal: Bioorganic chemistry

Published: January 28, 2026

Bicyclic Lactams From Chiral Imines: Synthesis, Structural Optimization, and Biological Evaluation of Promising Antileishmanial Agents.

Bicyclic Lactams From Chiral Imines: Synthesis, Structural Optimization, and Biological Evaluation of Promising Antileishmanial Agents.

Journal: ChemMedChem

Published: January 11, 2026

Discovery of 6,7-dimethoxyquinazoline-hydrazide hybrids as dual inhibitors of acetylcholinesterase and β-secretase.

Discovery of 6,7-dimethoxyquinazoline-hydrazide hybrids as dual inhibitors of acetylcholinesterase and β-secretase.

Journal: Biochimie

Published: December 04, 2025

Eyes on the future: PVA-hydrogel lenses as a platform for amphotericin B ocular delivery.

Eyes on the future: PVA-hydrogel lenses as a platform for amphotericin B ocular delivery.

Journal: International journal of pharmaceutics

Published: October 23, 2025

Eyes on the future: PVA-hydrogel lenses as a platform for amphotericin B ocular delivery.

Eyes on the future: PVA-hydrogel lenses as a platform for amphotericin B ocular delivery.

Journal: International journal of pharmaceutics

Published: October 23, 2025

In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia.

In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia.

Journal: Toxicology and applied pharmacology

Published: October 16, 2025

Editorial: Drug discovery for leishmaniasis and chagas disease: compound design and therapeutic strategies.

Editorial: Drug discovery for leishmaniasis and chagas disease: compound design and therapeutic strategies.

Journal: Frontiers in pharmacology

Published: October 03, 2025

In silico target identification and pharmacokinetic profiling of 2-aryl-quinoline-4-carboxylic acid derivatives as potential antileishmanial agents.

In silico target identification and pharmacokinetic profiling of 2-aryl-quinoline-4-carboxylic acid derivatives as potential antileishmanial agents.

Journal: Frontiers in pharmacology

Published: April 30, 2025

Apoptosis and G2/M Phase Cell Cycle Arrest Induced by Alkaloid Erythraline Isolated from Erythrina velutina in SiHa Cervical Cancer Cell.

Apoptosis and G2/M Phase Cell Cycle Arrest Induced by Alkaloid Erythraline Isolated from Erythrina velutina in SiHa Cervical Cancer Cell.

Journal: International journal of molecular sciences

Published: December 19, 2024

Solvatochromic fluorophores based on 6-fluoro-2-(aryl)quinoline-4-carboxylic acids: Synthesis, optical studies and evaluation of their antimicrobial and larvicidal properties.

Solvatochromic fluorophores based on 6-fluoro-2-(aryl)quinoline-4-carboxylic acids: Synthesis, optical studies and evaluation of their antimicrobial and larvicidal properties.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: October 28, 2024

Selective inhibition of interleukin 6 receptor decreased inflammatory cytokines and increased proteases in an experimental model of critical calvarial defect.

Selective inhibition of interleukin 6 receptor decreased inflammatory cytokines and increased proteases in an experimental model of critical calvarial defect.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica

Published: February 21, 2024

The Power of Molecular Dynamics Simulations and Their Applications to Discover Cysteine Protease Inhibitors.

The Power of Molecular Dynamics Simulations and Their Applications to Discover Cysteine Protease Inhibitors.

Journal: Mini reviews in medicinal chemistry

Published: March 25, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026